UK Markets closed

Valneva SE American Depositary Shares (VALN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.35-2.31 (-6.13%)
At close: 04:00PM EST
35.05 -0.30 (-0.85%)
After hours: 07:21PM EST
Full screen
Trade prices are not sourced from all markets
Previous close37.66
Bid35.00 x 1300
Ask39.98 x 900
Day's range34.83 - 36.17
52-week range24.16 - 67.84
Avg. volume94,877
Market cap1.874B
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant

    Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.

  • Reuters

    Shares in COVID-19 vaccine developer Valneva extend fall

    Shares in biotech company Valneva fell again on Wednesday, declining for the seventh day in a row due to a growing belief amongst investors that the COVID-19 Omicron variant might lessen the need for mass vaccination. At 0945 GMT, Valneva shares were down 3% at 17.10 euros, meaning the stock has now lost close to 40% since its Dec. 27 close of 26.38 euros. It did gain more than 200% a year in 2021 and 2020 as Valneva's COVID-19 vaccine candidate came increasingly closer to approval.

  • Motley Fool

    Is This New Data on Valneva's Less-Effective Booster Concerning?

    Some recent dismal results for Valneva's vaccine looked bad. But there could be more to the story.